XPO1 and prostate cancer: Compared to normal tissue controls, however, the relocation of E2F7, but not E2F1, from the nucleus to the cytoplasm is induced by the overexpressed XPO1, and is commonly observed in colorectal cancer, prostate cancer, breast cancer, and HNSCC.